Related Experiment Video

Updated: Jun 2, 2026

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
10:59

Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein

Published on: June 6, 2025

Fragile x syndrome and autism: from disease model to therapeutic targets

Gül Dölen1, Mark F Bear

  • 1Department of Brain and Cognitive Sciences, Howard Hughes Medical Institute, The Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA, guldolen@gmail.com.

Journal of Neurodevelopmental Disorders
|May 7, 2011
PubMed

Insights

Fragile X syndrome (FXS) research in mice identified metabotropic glutamate receptor 5 (mGluR5) as a potential therapeutic target. This finding may extend to treating other autism causes due to shared molecular pathways.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Autism spectrum disorder (ASD) encompasses diverse etiologies.
  • Fragile X syndrome (FXS) is a leading genetic cause of ASD.
  • FXS has been successfully modeled in Fmr1 knockout mice.

Purpose of the Study:

  • To identify novel therapeutic targets for FXS.
  • To explore the potential of targeting metabotropic glutamate receptor 5 (mGluR5) for FXS treatment.
  • To investigate if FXS therapeutic targets could benefit broader ASD populations.

Main Methods:

  • Utilizing Fmr1 knockout mouse models for FXS.
  • Investigating the role of metabotropic glutamate receptor 5 (mGluR5) signaling.
  • Analyzing interactions between mGluR5 and synaptic proteins implicated in autism.

Main Results:

  • Identification of mGluR5 as a putative therapeutic target for FXS.
  • mGluR5 signaling pathways are linked to various synaptic proteins.
  • These proteins are frequently implicated in the pathophysiology of autism.

Conclusions:

  • Targeting mGluR5 shows promise for FXS treatment.
  • Shared molecular mechanisms suggest potential efficacy for other autism etiologies.
  • This research opens avenues for broader autism therapeutics.

More Related Videos

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation11:10

Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation

Published on: July 6, 2022

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism08:44

Dynamic Clamp Methods to Investigate Impaired Neuronal Excitability Associated with Autism

Published on: October 17, 2025

Related Concept Videos

Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...